Excess triglyceride-derived lipid intermediates can disrupt membrane lipid composition, activate the PKC and JNK pathways, and promote chronic inflammation, creating a tumor-permissive microenvironment (31–34). The gene discussed is PRRT2; the disease is neoplasm.